Form 8-K - Current report:
SEC Accession No. 0001104659-23-001850
Filing Date
2023-01-06
Accepted
2023-01-06 16:05:17
Documents
40
Period of Report
2023-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm232502d1_8k.htm   iXBRL 8-K 27891
2 EXHIBIT 99.1 tm232502d1_ex99-1.htm EX-99.1 39319
6 GRAPHIC tm232502d1_ex99-1img001.jpg GRAPHIC 110099
7 GRAPHIC tm232502d1_ex99-1img002.jpg GRAPHIC 216481
8 GRAPHIC tm232502d1_ex99-1img003.jpg GRAPHIC 204052
9 GRAPHIC tm232502d1_ex99-1img004.jpg GRAPHIC 160315
10 GRAPHIC tm232502d1_ex99-1img005.jpg GRAPHIC 101209
11 GRAPHIC tm232502d1_ex99-1img006.jpg GRAPHIC 147504
12 GRAPHIC tm232502d1_ex99-1img007.jpg GRAPHIC 179821
13 GRAPHIC tm232502d1_ex99-1img008.jpg GRAPHIC 124097
14 GRAPHIC tm232502d1_ex99-1img009.jpg GRAPHIC 150620
15 GRAPHIC tm232502d1_ex99-1img010.jpg GRAPHIC 175502
16 GRAPHIC tm232502d1_ex99-1img011.jpg GRAPHIC 141628
17 GRAPHIC tm232502d1_ex99-1img012.jpg GRAPHIC 137215
18 GRAPHIC tm232502d1_ex99-1img013.jpg GRAPHIC 140647
19 GRAPHIC tm232502d1_ex99-1img014.jpg GRAPHIC 132411
20 GRAPHIC tm232502d1_ex99-1img015.jpg GRAPHIC 114345
21 GRAPHIC tm232502d1_ex99-1img016.jpg GRAPHIC 132146
22 GRAPHIC tm232502d1_ex99-1img017.jpg GRAPHIC 114784
23 GRAPHIC tm232502d1_ex99-1img018.jpg GRAPHIC 117787
24 GRAPHIC tm232502d1_ex99-1img019.jpg GRAPHIC 148767
25 GRAPHIC tm232502d1_ex99-1img020.jpg GRAPHIC 140403
26 GRAPHIC tm232502d1_ex99-1img021.jpg GRAPHIC 241929
27 GRAPHIC tm232502d1_ex99-1img022.jpg GRAPHIC 178391
28 GRAPHIC tm232502d1_ex99-1img023.jpg GRAPHIC 176459
29 GRAPHIC tm232502d1_ex99-1img024.jpg GRAPHIC 153146
30 GRAPHIC tm232502d1_ex99-1img025.jpg GRAPHIC 73653
31 GRAPHIC tm232502d1_ex99-1img026.jpg GRAPHIC 153177
32 GRAPHIC tm232502d1_ex99-1img027.jpg GRAPHIC 92255
  Complete submission text file 0001104659-23-001850.txt   5709596

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anvs-20230106.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anvs-20230106_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anvs-20230106_pre.xml EX-101.PRE 22599
34 EXTRACTED XBRL INSTANCE DOCUMENT tm232502d1_8k_htm.xml XML 3707
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 23515085
SIC: 2834 Pharmaceutical Preparations